She adds that starting with a lower dose of 2 mg/week instead of 4 mg/week may help mitigate adverse effects
others are supported primarily by observational data and patient-reported outcomes rather than large controlled trials
Therefore, we recommend that you keep your prescription and delivery details ready to avoid delays during verification and dispatch
Side Effects and Safety Side effects Across preclinical studies and the small human trials published to date (~28 subjects across pilot studies), the reported adverse events stay limited: Mild injection-site irritation (rare) No systemic toxicity at therapeutic doses in published reports Oral administration: mild GI upset in sensitive individuals No immunosuppression, hormonal disruption, or metabolic side effects have been observed
Store in a cool, dry environment away from direct light
For example, MEK inhibition leads to strong overrepresentation of ERK1/2 motif as expected, GSK3 inhibition down-regulates sites that conform to the known GSK3 motif, and mTOR inhibition down-regulated sites with the known mTOR substrate motif as well as substrate sites of its main downstream kinase p70S6K
